Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 48.40 million. The enterprise value is 56.25 million.

Market Cap	48.40M
Enterprise Value	56.25M

Important Dates

The next confirmed earnings date is Wednesday, October 14, 2026.

Earnings Date	Oct 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 73.11 million shares outstanding.

Current Share Class	73.11M
Shares Outstanding	73.11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.42%
Owned by Institutions (%)	3.60%
Float	39.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	100.83
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	117.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-54.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.54%
Revenue Per Employee	13,333
Profits Per Employee	-187,722
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-812,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.54% in the last 52 weeks. The beta is 0.42, so Theraclion's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-10.54%
50-Day Moving Average	0.66
200-Day Moving Average	0.61
Relative Strength Index (RSI)	45.98
Average Volume (20 Days)	71,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 480,000 and -6.76 million in losses.

Revenue	480,000
Gross Profit	-4.29M
Operating Income	-8.79M
Pretax Income	-7.57M
Net Income	-6.76M
EBITDA	-8.44M
EBIT	-8.79M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	351,000
Net Borrowing	n/a
Free Cash Flow	-7.16M
FCF Per Share	-0.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,831.88%
Pretax Margin	-1,577.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.96%
FCF Yield	-14.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a